PR

Precision Biosensor Inc.

Develops sensitive point-of-care biomarker diagnostics for human and animal health.

335810 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전시 유성구 테크노2로 306, 대전시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Precision Biosensor Inc. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells point-of-care testing (POCT) solutions. The company specializes in biomarker diagnostics, offering a range of clinical diagnostic products for both human and animal healthcare. Its core offerings are built upon a proprietary time-resolved fluorescence (TRF) immunoassay technology, designed to deliver highly sensitive and accurate results for on-site diagnosis. The product line includes diagnostic devices and reagents for immuno-diagnosis and clinical chemistry, aiming to provide optimized solutions for rapid clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-01 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.6 KB
2025-07-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.4 KB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.1 KB
2025-04-02 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 23.2 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.1 KB
2025-03-27 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.8 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 491.4 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 156.0 KB

Automate Your Workflow. Get a real-time feed of all Precision Biosensor Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Precision Biosensor Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.